PIEZO1 and neoplasm: There is evidence to suggest that the combination of Piezo1 antibody and MMAE can not only promote tumor cell cycle arrest and apoptosis, but also slow down the development of ESCC xenograft tumor models without any side effects (Qin et al., 2022).